Cargando…
Endogenous estrogens—breast cancer and chemoprevention
Breast cancer is the most common female malignancy and the second leading cause of cancer related deaths. It is estimated that about 40% of all cancer in women is hormonally mediated. Both estrogens and androgens play critical roles in the initiation and development of breast cancer. Estrogens influ...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599256/ https://www.ncbi.nlm.nih.gov/pubmed/34462889 http://dx.doi.org/10.1007/s43440-021-00317-0 |
_version_ | 1784600909138886656 |
---|---|
author | Starek-Świechowicz, Beata Budziszewska, Bogusława Starek, Andrzej |
author_facet | Starek-Świechowicz, Beata Budziszewska, Bogusława Starek, Andrzej |
author_sort | Starek-Świechowicz, Beata |
collection | PubMed |
description | Breast cancer is the most common female malignancy and the second leading cause of cancer related deaths. It is estimated that about 40% of all cancer in women is hormonally mediated. Both estrogens and androgens play critical roles in the initiation and development of breast cancer. Estrogens influence normal physiological growth, proliferation, and differentiation of breast tissues, as well as the development and progression of breast malignancy. Breast cancer is caused by numerous endo- and exogenous risk factors. The paper presents estrogen metabolism, in particular 17β-estradiol and related hormones. The mechanisms of estrogen carcinogenesis include the participation of estrogen receptors, the genotoxic effect of the estrogen metabolites, and epigenetic processes that are also presented. The role of reactive oxygen species in breast cancer has been described. It called attention to a role of numerous signaling pathways in neoplastic transformation. Chemoprotective agents, besides other phytoestrogens, classical antioxidants, synthetic compounds, and their mechanisms of action have been shown. |
format | Online Article Text |
id | pubmed-8599256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-85992562021-11-24 Endogenous estrogens—breast cancer and chemoprevention Starek-Świechowicz, Beata Budziszewska, Bogusława Starek, Andrzej Pharmacol Rep Review Breast cancer is the most common female malignancy and the second leading cause of cancer related deaths. It is estimated that about 40% of all cancer in women is hormonally mediated. Both estrogens and androgens play critical roles in the initiation and development of breast cancer. Estrogens influence normal physiological growth, proliferation, and differentiation of breast tissues, as well as the development and progression of breast malignancy. Breast cancer is caused by numerous endo- and exogenous risk factors. The paper presents estrogen metabolism, in particular 17β-estradiol and related hormones. The mechanisms of estrogen carcinogenesis include the participation of estrogen receptors, the genotoxic effect of the estrogen metabolites, and epigenetic processes that are also presented. The role of reactive oxygen species in breast cancer has been described. It called attention to a role of numerous signaling pathways in neoplastic transformation. Chemoprotective agents, besides other phytoestrogens, classical antioxidants, synthetic compounds, and their mechanisms of action have been shown. Springer International Publishing 2021-08-30 2021 /pmc/articles/PMC8599256/ /pubmed/34462889 http://dx.doi.org/10.1007/s43440-021-00317-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Starek-Świechowicz, Beata Budziszewska, Bogusława Starek, Andrzej Endogenous estrogens—breast cancer and chemoprevention |
title | Endogenous estrogens—breast cancer and chemoprevention |
title_full | Endogenous estrogens—breast cancer and chemoprevention |
title_fullStr | Endogenous estrogens—breast cancer and chemoprevention |
title_full_unstemmed | Endogenous estrogens—breast cancer and chemoprevention |
title_short | Endogenous estrogens—breast cancer and chemoprevention |
title_sort | endogenous estrogens—breast cancer and chemoprevention |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599256/ https://www.ncbi.nlm.nih.gov/pubmed/34462889 http://dx.doi.org/10.1007/s43440-021-00317-0 |
work_keys_str_mv | AT starekswiechowiczbeata endogenousestrogensbreastcancerandchemoprevention AT budziszewskabogusława endogenousestrogensbreastcancerandchemoprevention AT starekandrzej endogenousestrogensbreastcancerandchemoprevention |